Henry Schein, Inc.

Healthcare

NASDAQ:HSIC · NASDAQ Global Select

Market Cap $9.14B Beta 0.82 P/E (TTM) 23.8

$81.25 +1.91%

+$1.53 today

52W Low $61.95High $89.29

Vol 1.08M · Avg 1.38M

EPS (TTM)$3.44

Medical - Distribution

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+15.76%

Period High

$83.35

Period Low

$62.03

Latest

$81.25

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.47B

Globus Medical, Inc.

NYSE:GMED

$10.87B

Molina Healthcare, Inc.

NYSE:MOH

$10.43B

Masimo Corporation

NASDAQ:MASI

$9.42B

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$8.26B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.72B

AptarGroup, Inc.

NYSE:ATR

$7.54B

Avantor, Inc.

NYSE:AVTR

$6.54B

Grifols, S.A.

NASDAQ:GRFS

$6.50B

What is the latest HSIC filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does HSIC have?

Intrinsic Alpha currently shows 20 recent filings for HSIC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.